The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world event-free survival (rwEFS) and overall survival (rwOS) in elderly patients with resected locoregionally advanced head and neck squamous cell carcinoma (LA HNSCC) in the US.
 
Dandan Zheng
Employment - Abbvie (I); Merck
 
Su Zhang
Other Relationship - Analysis Group (Inst)
 
Behzad Bidadi
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Nati Lerman
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Yan Song
Other Relationship - Analysis Group (Inst)
 
Rui Song
Other Relationship - Analysis Group
 
Jiayang Li
Other Relationship - Analysis Group (Inst)
 
Anyu Zhu
Other Relationship - Analysis Group (Inst)
 
Yuexin Tang
Employment - BMS; JnJ (I); Merck
Stock and Other Ownership Interests - BMS; JnJ (I); Merck
 
James Signorovitch
Other Relationship - Analysis Group (Inst)
 
Sanjay Merchant
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Glenn J. Hanna
Employment - Dana-Farber Cancer Institute
Honoraria - Massachusetts Medical Society
Consulting or Advisory Role - Bicara Therapeutics; Boxer Capital; Bristol-Myers Squibb; Coherus Biosciences; Coherus Biosciences; Elevar Therapeutics; Grey Wolf Therapeutics; InhibRx; KSQ Therapeutics; Kura Oncology; Merck; Naveris; Nextech Invest; PDS Biotechnology; Remix Therapeutics; Replimune; Surface Oncology
Research Funding - Actuate Therapeutics (Inst); Adenoid Cystic Carcinoma Research Foundation (Inst); ASCO (Inst); Bicara Therapeutics (Inst); Bristol-Myers Squibb (Inst); Gateway for Cancer Research; Genentech (Inst); ImmunityBio (Inst); Kura Oncology (Inst); Regeneron (Inst); Secura Bio (Inst)